Go Pro

Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$14.70 -0.22 (-1.47%)
Closing price 08/24/2026 04:00 PM Eastern
Extended Trading
$14.77 +0.07 (+0.48%)
As of 04:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DRTS vs. LIVN, ITGR, IRTC, HAE, and PLSE

Should you buy Alpha Tau Medical stock or one of its competitors? Alpha Tau Medical's main competitors and comparable companies include LivaNova (LIVN), Integer (ITGR), iRhythm Technologies (IRTC), Haemonetics (HAE), and Pulse Biosciences (PLSE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Alpha Tau Medical compare to LivaNova?

Alpha Tau Medical (NASDAQ:DRTS) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

Alpha Tau Medical has higher earnings, but lower revenue than LivaNova. Alpha Tau Medical is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A
LivaNova$1.39B3.11-$242.47M$3.3823.15

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Comparatively, 0.4% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

LivaNova has a net margin of 12.82% compared to Alpha Tau Medical's net margin of 0.00%. LivaNova's return on equity of 16.35% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -138.12% -81.68%
LivaNova 12.82%16.35%7.76%

Alpha Tau Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

Alpha Tau Medical currently has a consensus price target of $12.80, suggesting a potential downside of 12.93%. LivaNova has a consensus price target of $83.50, suggesting a potential upside of 6.70%. Given LivaNova's stronger consensus rating and higher probable upside, analysts plainly believe LivaNova is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50
LivaNova
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55

In the previous week, LivaNova had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 4 mentions for LivaNova and 1 mentions for Alpha Tau Medical. LivaNova's average media sentiment score of 0.14 beat Alpha Tau Medical's score of 0.00 indicating that LivaNova is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LivaNova
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

LivaNova beats Alpha Tau Medical on 12 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to Integer?

Integer (NYSE:ITGR) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

Integer currently has a consensus price target of $109.86, suggesting a potential downside of 12.04%. Alpha Tau Medical has a consensus price target of $12.80, suggesting a potential downside of 12.93%. Given Integer's higher possible upside, research analysts plainly believe Integer is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
13 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.07
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

99.3% of Integer shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 1.1% of Integer shares are held by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Integer had 8 more articles in the media than Alpha Tau Medical. MarketBeat recorded 9 mentions for Integer and 1 mentions for Alpha Tau Medical. Integer's average media sentiment score of 1.26 beat Alpha Tau Medical's score of 0.00 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Integer has a net margin of 6.97% compared to Alpha Tau Medical's net margin of 0.00%. Integer's return on equity of 12.79% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.97% 12.79% 6.48%
Alpha Tau Medical N/A -138.12%-81.68%

Integer has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

Integer has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.85B2.29$102.81M$3.6634.12
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

Summary

Integer beats Alpha Tau Medical on 11 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

iRhythm Technologies has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to iRhythm Technologies' net margin of -1.69%. iRhythm Technologies' return on equity of 10.11% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-1.69% 10.11% 1.53%
Alpha Tau Medical N/A -138.12%-81.68%

2.7% of Alpha Tau Medical shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

iRhythm Technologies presently has a consensus price target of $179.93, suggesting a potential upside of 43.66%. Alpha Tau Medical has a consensus price target of $12.80, suggesting a potential downside of 12.93%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe iRhythm Technologies is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, iRhythm Technologies had 5 more articles in the media than Alpha Tau Medical. MarketBeat recorded 6 mentions for iRhythm Technologies and 1 mentions for Alpha Tau Medical. iRhythm Technologies' average media sentiment score of 0.50 beat Alpha Tau Medical's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alpha Tau Medical has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$747.14M5.53-$44.55M-$0.43N/A
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

Summary

iRhythm Technologies beats Alpha Tau Medical on 11 of the 16 factors compared between the two stocks.

How does Alpha Tau Medical compare to Haemonetics?

Haemonetics (NYSE:HAE) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 2.1% of Haemonetics shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Haemonetics has a net margin of 7.12% compared to Alpha Tau Medical's net margin of 0.00%. Haemonetics' return on equity of 27.55% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Haemonetics7.12% 27.55% 9.65%
Alpha Tau Medical N/A -138.12%-81.68%

Haemonetics currently has a consensus price target of $97.56, indicating a potential downside of 9.96%. Alpha Tau Medical has a consensus price target of $12.80, indicating a potential downside of 12.93%. Given Haemonetics' stronger consensus rating and higher probable upside, equities analysts clearly believe Haemonetics is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haemonetics
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Haemonetics had 22 more articles in the media than Alpha Tau Medical. MarketBeat recorded 23 mentions for Haemonetics and 1 mentions for Alpha Tau Medical. Haemonetics' average media sentiment score of 0.96 beat Alpha Tau Medical's score of 0.00 indicating that Haemonetics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haemonetics
13 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Haemonetics has a beta of 0.52, suggesting that its stock price is 48% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, suggesting that its stock price is 17% more volatile than the broader market.

Haemonetics has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haemonetics$1.35B3.65$97.31M$2.0453.11
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

Summary

Haemonetics beats Alpha Tau Medical on 14 of the 16 factors compared between the two stocks.

How does Alpha Tau Medical compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability.

Alpha Tau Medical has lower revenue, but higher earnings than Pulse Biosciences. Pulse Biosciences is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pulse Biosciences$350K9,715.11-$72.78M-$1.18N/A
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

Alpha Tau Medical has a net margin of 0.00% compared to Pulse Biosciences' net margin of -6,755.78%. Pulse Biosciences' return on equity of -94.42% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Pulse Biosciences-6,755.78% -94.42% -79.96%
Alpha Tau Medical N/A -138.12%-81.68%

77.0% of Pulse Biosciences shares are held by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are held by institutional investors. 74.0% of Pulse Biosciences shares are held by company insiders. Comparatively, 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Pulse Biosciences presently has a consensus price target of $45.25, suggesting a potential downside of 7.90%. Alpha Tau Medical has a consensus price target of $12.80, suggesting a potential downside of 12.93%. Given Pulse Biosciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe Pulse Biosciences is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pulse Biosciences
1 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.60
Alpha Tau Medical
1 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Pulse Biosciences had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 4 mentions for Pulse Biosciences and 1 mentions for Alpha Tau Medical. Pulse Biosciences' average media sentiment score of 0.67 beat Alpha Tau Medical's score of 0.00 indicating that Pulse Biosciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Pulse Biosciences
1 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Pulse Biosciences has a beta of 1.61, meaning that its share price is 61% more volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.17, meaning that its share price is 17% more volatile than the broader market.

Summary

Pulse Biosciences beats Alpha Tau Medical on 10 of the 15 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.35B$5.98B$7.36B$12.81B
Dividend YieldN/A1.75%2.54%10.78%
P/E Ratio-14.1326.04270.5624.05
Price / SalesN/A79.75639.15105.26
Price / CashN/A33.7129.0336.89
Price / Book16.706.1811.216.40
Net Income-$42.63M$149.30M$3.46B$347.95M
7 Day Performance3.09%0.45%1.74%1.49%
1 Month Performance17.60%8.91%7.34%5.15%
1 Year Performance357.94%7.84%26.13%17.01%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
1.0625 of 5 stars
$14.70
-1.5%
$12.80
-12.9%
+365.2%$1.35BN/AN/A80
LIVN
LivaNova
2.7064 of 5 stars
$79.86
-2.0%
$83.50
+4.6%
+40.0%$4.53B$1.39B23.633,300
ITGR
Integer
2.5941 of 5 stars
$125.11
+0.0%
$109.86
-12.2%
+12.9%$4.26B$1.85B34.1811,000
IRTC
iRhythm Technologies
3.8145 of 5 stars
$115.24
-1.4%
$179.93
+56.1%
-25.9%$4.17B$747.14MN/A2,400
HAE
Haemonetics
2.0922 of 5 stars
$104.94
+16.2%
$92.44
-11.9%
+92.5%$4.13B$1.33B51.443,009

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 8/25/2026 by MarketBeat.com Staff.
From Our Partners